Health Canada warns about use of pain killer Celebrex due to heart risk

TORONTO (CP) - Health Canada has pulled authorization of pain relief drug Celebrex for the treatment of a rare genetic disease, following "new information" linking the drug to an increased risk of heart attack. The department has withdrawn authorization for Pfizer Inc....More